Intrinsiqs

Is Gilead Sciences, Inc. overvalued?

Gilead Sciences, Inc. (GILD) looks overvalued — trading about 28% above its fair value.

Overvalued
Current price $168.08 Fair value $121.32
Price
$168.08
Fair value
$121.32
Current P/E
24.8
Normal P/E
17.9
Market cap
$208.48B
Dividend yield
1.9%
Return on equity
-21.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GILD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.